Return to study ST000468 main page

MB Sample ID: SA023657

Local Sample ID:OG1RF_1 Decoy
Subject ID:SU000489
Subject Type:Bacterial cells
Subject Species:Enterococcus faecalis
Taxonomy ID:1351
Genotype Strain:OG1RF
Species Group:Microorganism

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU000489
Subject Type:Bacterial cells
Subject Species:Enterococcus faecalis
Taxonomy ID:1351
Genotype Strain:OG1RF
Species Group:Microorganism

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
OG1RF_1 DecoySA023657FL005719Decoyinine, 0.1mg/mLExposure

Collection:

Collection ID:CO000483
Collection Summary:After the 15 minute treatment interval, 20mL sample will be harvested by filtration onto 0.45uM nitrocellulose membrane. The cells will be scraped off of the membrane into ice-cold PBS (~1mL), centrifuged for 45 seconds at 12K RPM, liquid aspirated and stored at -80C until sending for analysis.
Sample Type:Bacterial cells
Collection Method:Fast filtration
Volumeoramount Collected:20ml
Storage Conditions:-80C

Treatment:

Treatment ID:TR000503
Treatment Summary:Triplicate cultures of E. faecalis OG1RF will be grown in FMC-AUG to OD600 = 0.25. The cultures will be split into 3 equal volumes of 30mL which will be exposed to 100uL DMSO, 0.01mg/mL mupirocin, or 0.1mg/mL decoyinine for 15 minutes. At this point, 10mL sample will be removed for protein analysis. The remaining 20mL will be harvested by fast filtration for analysis.|Triplicate cultures of E. faecalis OG1RF will be grown in FMC-AUG to OD600 = 0.25. The cultures will be split into 3 equal volumes of 30mL which will be exposed to 100uL DMSO, 0.01mg/mL mupirocin, or 0.1mg/mL decoyinine for 15 minutes. At this point, 10mL sample will be removed for protein analysis. The remaining 20mL will be harvested by fast filtration for analysis.|Triplicate cultures of E. faecalis OG1RF will be grown in FMC-AUG to OD600 = 0.25. The cultures will be split into 3 equal volumes of 30mL which will be exposed to 100uL DMSO, 0.01mg/mL mupirocin, or 0.1mg/mL decoyinine for 15 minutes. At this point, 10mL sample will be removed for protein analysis. The remaining 20mL will be harvested by fast filtration for analysis.
Treatment Compound:DMSO|Mupirocin|Decoyinine
Treatment Dose:100uL|0.01mg/mL|0.1mg/mL
Treatment Doseduration:15 min|15 min|15 min
Treatment Vehicle:DMSO|DMSO|DMSO

Sample Preparation:

Sampleprep ID:SP000496
Sampleprep Summary:NAD-ATP
Sampleprep Protocol Filename:SB_NAD-ATP_Assay_Agilent.pdf

Combined analysis:

Analysis ID AN000731
Analysis type MS
Chromatography type Reversed phase
Chromatography system Agilent 1290 Infinity
Column Thermo Hypercarb (50 x 2.1mm,3um)
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Agilent 6490 QQQ
Ion Mode POSITIVE
Units nmol/mg protein

Chromatography:

Chromatography ID:CH000524
Chromatography Summary:NAD-ATP
Methods Filename:SB_NAD-ATP_Assay_Agilent.pdf
Instrument Name:Agilent 1290 Infinity
Column Name:Thermo Hypercarb (50 x 2.1mm,3um)
Chromatography Type:Reversed phase

MS:

MS ID:MS000648
Analysis ID:AN000731
Instrument Name:Agilent 6490 QQQ
Instrument Type:Triple quadrupole
MS Type:ESI
Ion Mode:POSITIVE
Analysis Protocol File:SB_NAD-ATP_Assay_Agilent.pdf
  logo